PAVM PAVmed: Company Value to Revenue

Public company logo of PAVmed, Inc. (PAVM)

PAVmed Inc. is developing a network of laboratories and patents in niche markets, creating diagnostics for esophageal cancer. This EV/Sales multiple chart illustrates the business valuation dynamics, where the 24000.00 mark indicates the valuation level. Despite pressure from industry behemoths with established distribution channels, the brand maintains a flawless image and high physician confidence in its engineering solutions.

PAVmed, Inc. (PAVM): EV/Sales Multiple from 11/23/2025 to 11/20/2026

PAVmed - analytical breakdowns and key metrics (PAVM)

- current price and projected stock value:
- company stock capitalization data:
Fundamental company valuation:PAVM - PAVmed Inc
Original product of pavmed.com

When constructing a long-term portfolio, it is critical to eliminate overvalued assets by utilizing a filter of enterprise value to revenue minus net debt. This indicator measures the real acquisition price of a company per unit of sales, which, given PAVmed Inc. (PAVM) focus on the organic development of IT projects and a pause in M&A, allows the enterprise value to revenue trend to signal the risk of unjustified multiple expansion in a timely manner.